Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- N/A
Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
TNF in Melanoma Patients Treated With Immunotherapy
- Status
- COMPLETED
- Phase
- NA
Fecal Microbiota Transplant (FMT) in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Dabrafenib and/or Trametinib Rollover Study
- Status
- RECRUITING
- Phase
- PHASE4
Suicide Plus Immune Gene Therapy for Advanced Melanoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Optimization of the Patient Care Pathway in Immuno-oncology
- Status
- COMPLETED
- Phase
- NA
Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma
- Status
- COMPLETED
- Phase
- NA
Post-ATU Study of Nivolumab
- Status
- COMPLETED
- Phase
- N/A
EPR Tumor Oximetry With CE India Ink
- Status
- TERMINATED
- Phase
- N/A
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
- Status
- UNKNOWN
- Phase
- PHASE4
Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer
- Status
- TERMINATED
- Phase
- PHASE2